Healthcare provider profile · identity verified

Kibibi Gaughan, M.D.

Family Practice · LEBANON, PA · NPI 1902957905

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	211	64
Omeprazole	Omeprazole	174	54
Levothyroxine Sodium	Levothyroxine Sodium	171	49
Lisinopril	Lisinopril	166	47
Simvastatin	Simvastatin	165	48
Amlodipine Besylate	Amlodipine Besylate	163	48
Losartan Potassium	Losartan Potassium	122	33
Metformin Hcl	Metformin Hcl	114	36
Metoprolol Tartrate	Metoprolol Tartrate	110	30
Metoprolol Succinate	Metoprolol Succinate	108	29
Albuterol Sulfate Hfa	Albuterol Sulfate	102	47
Furosemide	Furosemide	98	26
Rosuvastatin Calcium	Rosuvastatin Calcium	97	35
Hydrochlorothiazide	Hydrochlorothiazide	86	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	75	22
Pantoprazole Sodium	Pantoprazole Sodium	69	26
Escitalopram Oxalate	Escitalopram Oxalate	62	15
Clopidogrel	Clopidogrel Bisulfate	54	14
Alendronate Sodium	Alendronate Sodium	53	13
Gabapentin	Gabapentin	51	21
Fluticasone Propionate	Fluticasone Propionate	50	24
Lorazepam	Lorazepam	48	suppressed
Famotidine	Famotidine	47	18
Eliquis	Apixaban	46	suppressed
Atenolol	Atenolol	44	16
Synthroid	Levothyroxine Sodium	43	11
Prednisone	Prednisone	42	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	11
Duloxetine Hcl	Duloxetine Hcl	34	suppressed
Glipizide	Glipizide	34	11
Warfarin Sodium	Warfarin Sodium	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	12
Montelukast Sodium	Montelukast Sodium	29	suppressed
Xarelto	Rivaroxaban	28	suppressed
Carvedilol	Carvedilol	27	suppressed
Pravastatin Sodium	Pravastatin Sodium	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Potassium Chloride	Potassium Chloride	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	13
Enalapril Maleate	Enalapril Maleate	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Rybelsus	Semaglutide	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Baclofen	Baclofen	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	16
Metformin Hcl Er	Metformin Hcl	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Sertraline Hcl	Sertraline Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Trazodone Hcl	Trazodone Hcl	17	suppressed
Azithromycin	Azithromycin	15	14
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Allopurinol	Allopurinol	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	14
Galantamine Hbr	Galantamine Hbr	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Linzess	Linaclotide	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Moxifloxacin Hcl	Moxifloxacin Hcl	14	14
Nystatin	Nystatin	14	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error